Bajaj HealthCare Limited

Equities

BAJAJHCARE

INE411U01027

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:48 2024-04-30 am EDT 5-day change 1st Jan Change
325.4 INR -0.76% Intraday chart for Bajaj HealthCare Limited +2.50% -13.41%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bajaj Healthcare Bags Contract Manufacturing for APIs from UK, EU Customers; Shares Jump 14% MT
Bajaj Healthcare Limited Enters Definitive CDMO Agreement for 15 APIs with UK/EU Customers CI
Indian Equities Rebound, Helped by Gains in IT, Auto and Metal Stocks MT
Bajaj Healthcare CFO Steps Down MT
Bajaj Healthcare Limited Announces Executive Changes CI
Bajaj Healthcare Limited Announces Resignation of Rupesh Nikam as Chief Financial Officer CI
Bajaj HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Bajaj Healthcare Limited Announces Resignation of Aakashkumar Keshari from the Post of Company Secretary & Compliance Officer Effective CI
Bajaj Healthcare Limited Announces Resignation of Avinash K. Dalal as Non-Executive Independent Director CI
Bajaj Healthcare Appoints Chief Technical Officer MT
Bajaj Healthcare Limited Approves Appointment of Amit Rajan as Chief Technical Officer CI
Bajaj HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Bajaj Healthcare Commissions Alkaloid Extraction Plant MT
Bajaj Healthcare Completes Constrution of Alkaloid Extraction Plant in Gujarat, India MT
Bajaj Healthcare Limited Announces Successfully Completion of Construction of Alkaloid Extraction Plant at Vadodara, Gujarat Unit CI
Bajaj Healthcare Gets Vadodara, India Unit Inspection Report from US FDA MT
Bajaj Healthcare Swings to Loss in Fiscal Q1 MT
Bajaj HealthCare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Bajaj HealthCare Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Bajaj HealthCare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Bajaj Healthcare Limited Recommends Final Dividend for the Financial Year Ended 31St March, 2023 CI
Bajaj Healthcare Limited Announces Resignation of Luke Fernandez as Non-Executive Independent Director CI
Bajaj HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Bajaj Healthcare Unveils New Opium Processing Line in Gujarat, India MT
Bajaj HealthCare Limited inaugurates New Production Line for Processing of Opium At Savli, Gujarat, India and Commenced the Trial Run for the Same CI
Chart Bajaj HealthCare Limited
More charts
Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. Its segments include Bulk Drugs and Formulations. It is focused on development, manufacturing and supply of amino acids, nutritional supplements and API for pharmaceutical, nutraceuticals and food industries. Its APIs include ascorbic acid, CH Base and its derivatives, citicoline sodium, carbamazepine, theobromine, ferrous ascorbate, doxofylline, oxcarbazepine, choline bitartrate and its derivatives, octenidine dihydrochloride, vildagliptin, ticagrelor, diosmin, hesperidin and others. Its FDFs include Cellin 500, Septran DS Tablet, Vitajaj C tables 500mg, Ticajaj 90 tablets, Ecojaj 75mg & 150mg, Deferajaj 400mg & 500mg, Vildajaj 50mg and Vildajaj M 50/500. It also offers Inositol Nicotinate and Magnesium L-Threonate.
More about the company